- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 6 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)
GNP.2: 25 residues within 4Å:- Chain A: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.1
23 PLIP interactions:23 interactions with chain A- Hydrogen bonds: A:G.17, A:V.18, A:G.19, A:K.20, A:K.20, A:S.21, A:A.22, A:V.33, A:T.39, A:T.39, A:G.64, A:N.120, A:K.121, A:K.121, A:A.150, A:K.151
- Water bridges: A:S.21, A:S.21, A:D.37
- Salt bridges: A:D.123
- pi-Stacking: A:F.32, A:F.32
- pi-Cation interactions: A:K.121
GNP.5: 25 residues within 4Å:- Chain B: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.4
24 PLIP interactions:24 interactions with chain B- Hydrogen bonds: B:G.17, B:V.18, B:G.19, B:K.20, B:K.20, B:S.21, B:A.22, B:V.33, B:T.39, B:G.64, B:N.120, B:K.121, B:K.121, B:A.150, B:K.151
- Water bridges: B:S.21, B:S.21, B:S.21, B:D.37, B:T.39
- Salt bridges: B:D.123
- pi-Stacking: B:F.32, B:F.32
- pi-Cation interactions: B:K.121
GNP.8: 26 residues within 4Å:- Chain C: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, T.62, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.7
25 PLIP interactions:25 interactions with chain C- Hydrogen bonds: C:G.17, C:V.18, C:G.19, C:K.20, C:K.20, C:K.20, C:S.21, C:S.21, C:A.22, C:V.33, C:Y.36, C:T.39, C:G.64, C:N.120, C:K.121, C:K.121, C:S.149, C:A.150, C:K.151
- Water bridges: C:T.39, C:T.39
- Salt bridges: C:D.123
- pi-Stacking: C:F.32, C:F.32
- pi-Cation interactions: C:K.121
GNP.10: 25 residues within 4Å:- Chain D: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.11
24 PLIP interactions:24 interactions with chain D- Hydrogen bonds: D:G.17, D:V.18, D:G.19, D:K.20, D:K.20, D:S.21, D:A.22, D:V.33, D:T.39, D:T.62, D:G.64, D:N.120, D:K.121, D:K.121, D:S.149, D:A.150, D:K.151
- Water bridges: D:K.20, D:S.21, D:T.39
- Salt bridges: D:D.123
- pi-Stacking: D:F.32, D:F.32
- pi-Cation interactions: D:K.121
GNP.13: 25 residues within 4Å:- Chain E: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.12
26 PLIP interactions:26 interactions with chain E- Hydrogen bonds: E:G.17, E:V.18, E:G.19, E:K.20, E:K.20, E:K.20, E:S.21, E:A.22, E:V.33, E:Y.36, E:T.39, E:G.64, E:N.120, E:K.121, E:K.121, E:S.149, E:A.150, E:K.151
- Water bridges: E:S.21, E:S.21, E:T.39, E:T.39
- Salt bridges: E:D.123
- pi-Stacking: E:F.32, E:F.32
- pi-Cation interactions: E:K.121
GNP.15: 25 residues within 4Å:- Chain F: A.15, G.16, G.17, V.18, G.19, K.20, S.21, A.22, F.32, V.33, D.34, E.35, Y.36, P.38, T.39, A.63, G.64, N.120, K.121, D.123, L.124, S.149, A.150, K.151
- Ligands: MG.14
21 PLIP interactions:21 interactions with chain F- Hydrogen bonds: F:G.17, F:V.18, F:G.19, F:K.20, F:K.20, F:K.20, F:S.21, F:A.22, F:V.33, F:Y.36, F:T.39, F:G.64, F:N.120, F:K.121, F:K.121, F:A.150, F:K.151
- Salt bridges: F:D.123
- pi-Stacking: F:F.32, F:F.32
- pi-Cation interactions: F:K.121
- 4 x CVK: 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline(Non-covalent)
CVK.3: 10 residues within 4Å:- Chain A: K.9, L.10, V.11, S.43, R.45, D.58, L.60, Y.75, T.78
- Chain E: Q.3
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:K.9, A:V.11, A:R.45, A:D.58, A:L.60, A:T.78
- Hydrogen bonds: A:R.45
CVK.6: 13 residues within 4Å:- Chain B: K.9, L.10, V.11, S.43, Y.44, R.45, D.58, I.59, L.60, Y.75, T.78, G.79
- Chain C: Q.3
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:K.9, B:V.11, B:R.45, B:D.58, B:L.60, B:L.60
- pi-Cation interactions: B:R.45
CVK.9: 14 residues within 4Å:- Chain B: Q.3, E.7
- Chain C: E.7, K.9, L.10, V.11, S.43, Y.44, R.45, D.58, I.59, L.60, Y.75, T.78
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:K.9, C:V.11, C:R.45, C:D.58, C:L.60, C:L.60, C:T.78
- Hydrogen bonds: C:T.78
CVK.16: 11 residues within 4Å:- Chain D: Q.3
- Chain F: K.9, L.10, V.11, S.43, R.45, D.58, L.60, Y.75, T.78, G.79
8 PLIP interactions:8 interactions with chain F- Hydrophobic interactions: F:K.9, F:V.11, F:R.45, F:D.58, F:L.60, F:L.60, F:T.78
- Hydrogen bonds: F:T.78
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bery, N. et al., BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. Elife (2018)
- Release Date
- 2018-08-08
- Peptides
- GTPase KRas: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 6 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)
- 4 x CVK: 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bery, N. et al., BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. Elife (2018)
- Release Date
- 2018-08-08
- Peptides
- GTPase KRas: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
CD
DE
EF
F